Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

HK Type 4 license through Ballingal Investment Advisors Ltd. ("BIA" or "BIAL")

BACKGROUND
I have 20+yrs experience in Asia doing alternative strategies (i.e. non-delta1 non long-only) in fixed income, equity derivatives, and activist/catalyst/event-driven and long-short equity strategies with most of that time spent managing money. 

4 years in fixed income macro, 8 years running internal hedge fund and 4yrs investment banking at Citi in Japan, 3 years running an Asia multi-strat portfolio at a hedge fund, 4+yrs as an independent special situations analyst.

Pan-Asia Catalysts/Events

Medley (4480 JP): 2023 Result Beats Guidance; Sees Flat Profit on Double-Digit Sales Growth in 2024

Quiddity Advisors

Event-Driven

<ul>
<li>
<a href="https://www.smartkarma.com/entities/medley-inc" target="_blank" data-smartkarma-citation="entities:31041:1" rel="noopener">Medley (4480 JP)</a> operates recruitment platforms in healthcare, elsewhere. <a href="https://www.smartkarma.com/entities/guppy-s-inc" target="_blank" data-smartkarma-citation="entities:40692:1" rel="noopener">GUPPY's Inc (5127 JP)</a> does too. They also offer exam prep for two niches where they have super-high market share.</li>
<li>GUPPY's was listed 18mos ago, and the founder wants out. The deal is a nice premium (+86%) but it isn't as generous a deal as it could be. </li>
<li>That said, the shareholder structure looks like this deal gets done pretty easily. </li>
</ul>



Medley (4480 JP) operates recruitment platforms in healthcare, elsewhere. GUPPY's Inc (5127 JP) does too. They also offer exam prep for two niches where they have super-high market share.
GUPPY's was listed 18mos ago, and the founder wants out. The deal is a nice premium (+86%) but it isn't as generous a deal as it could be. 
That said, the shareholder structure looks like this deal gets done pretty easily. 


Medley (4480) To Buy Out Guppy's (5127) At ¥3,250 (9.4x Aug26 EV/FCF)